@conference{10902/13459,
year = {2017},
url = {http://hdl.handle.net/10902/13459},
abstract = {Photodynamic Therapy is a selective optical tumor destruction technique with practically no secondary effects. Monitoring by fluorescence photosensitizer emission is essential for an adequate treatment dosimetry, which avoids recurrence.},
organization = {This work has been partially supported by the project “New active phases in transition metals and rare earth nano-oxides stabilized at high pressure” (MAT2015-69508-P) of the Spanish Ministry of Economy and Competitiveness, cofunded by FEDER funds, and by the San Cándido Foundation.},
publisher = {SPIE Society of Photo-Optical Instrumentation Engineers-},
publisher = {The Optical Society (OSA)},
publisher = {F. Fanjul-Vélez, M. A. Rodríguez-Colmenares and J.L. Arce-Diego, “Fluorescence emission analysis of photodynamic therapy photosensitizer as a monitoring biomarker”, in European Conference on Biomedical Optics: Medical Laser Applications and Laser-Tissue Interactions VIII, Lothar D. Lilge and Ronald Sroka, eds., Vol. 10417 of Proc. of SPIE-OSA Biomedical Optics, 1041704, (2017)},
title = {Fluorescence emission analysis of photodynamic therapy photosensitizer as a monitoring biomarker},
author = {Fanjul Vélez, Félix and Rodríguez Colmenares, Miguel Alejandro and Arce Diego, José Luis},
}